Literature DB >> 6166564

Possible importance of macrophage-derived mediators in acute malaria.

I A Clark, J L Virelizier, E A Carswell, P R Wood.   

Abstract

Tumor necrosis factor, lymphocyte-activating factor, and enhanced levels of type I interferon were found in serum samples taken 2 h after mice infected with Plasmodium vinckei subsp. petteri received a small intravenous injection of endotoxin. These three mediators are among those released when mice receive an endotoxin injection 2 weeks after Mycobacterium bovis BCG or Corynebacterium parvum have been administered. There is indirect evidence that this wider range of mediators is also released in P. vinckei subsp. petteri-infected mice given parenteral endotoxin. A recent report that endotoxin is detectable in the plasma of malaria-infected mice and children implies that these mediators may also be released in the acute phase of the natural infection. We propose that these macrophage-derived mediators may be important in the glucocorticoid antagonism, bone marrow depression, fever, hypergammaglobulinemia, splenomegaly, elevation of serum amyloid A, consumptive coagulopathy, and shock syndrome with associated organ damage which can accompany malaria. The intraerythrocytic parasite death seen at crisis in some malarias, as well as the subsequent development of specific protective immunity, may also depend on these mediators.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6166564      PMCID: PMC351558          DOI: 10.1128/iai.32.3.1058-1066.1981

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  54 in total

1.  Effect of zymosan on endotoxin toxicity in mice.

Authors:  B BENACERRAF; G J THORBECKE; D JACOBY
Journal:  Proc Soc Exp Biol Med       Date:  1959-04

2.  Production by mixed lymphocyte cultures of a type II interferon able to protect macrophages against virus infection.

Authors:  J L Virelizier; A C Allison; E de Maeyer
Journal:  Infect Immun       Date:  1977-08       Impact factor: 3.441

3.  Physiological aspects of protozoan infection.

Authors:  B G MAEGRAITH
Journal:  Annu Rev Microbiol       Date:  1954       Impact factor: 15.500

4.  The immunological significance of histological changes in the spleen and liver in mouse malaria.

Authors:  C J Moran; V S De Rivera; J L Turk
Journal:  Clin Exp Immunol       Date:  1973-03       Impact factor: 4.330

5.  Depletion of coagulation factors in drug-resistant Plasmodium falciparum malaria.

Authors:  L H Dennis; J W Eichelberger; M M Inman; M E Conrad
Journal:  Blood       Date:  1967-05       Impact factor: 22.113

6.  Serum containing endotoxin-induced tumour necrosis factor substitutes for helper T cells.

Authors:  M K Hoffmann; S Green; L J Old; H F Oettgen
Journal:  Nature       Date:  1976-09-30       Impact factor: 49.962

7.  Prostaglandin and thromboxane synthesis in a pure macrophage population and the inhibition, by E-type prostaglandins, of chemiluminescence.

Authors:  M J Weidemann; B A Peskar; K Wrogemann; E T Rietschel; H Staudinger; H Fischer
Journal:  FEBS Lett       Date:  1978-05-01       Impact factor: 4.124

8.  The protective effect of endogenous interferon in mouse malaria, as demonstrated by the use of anti-interferon globulins.

Authors:  F Sauvaget; B Fauconnier
Journal:  Biomedicine       Date:  1978-10

9.  Does endotoxin cause both the disease and parasite death in acute malaria and babesiosis?

Authors:  I A Clark
Journal:  Lancet       Date:  1978-07-08       Impact factor: 79.321

10.  MODIFICATION OF HOST RESPONSES TO BACTERIAL ENDOTOXINS. I. SPECIFICITY OF PYROGENIC TOLERANCE AND THE ROLE OF HYPERSENSITIVITY IN PYROGENICITY, LETHALITY, AND SKIN REACTIVITY.

Authors:  D W WATSON; Y B KIM
Journal:  J Exp Med       Date:  1963-09-01       Impact factor: 14.307

View more
  92 in total

1.  Reassessment of the role of splenic leukocyte oxidative activity and macrophage activation in expression of immunity to malaria.

Authors:  L A Cavacini; M Guidotti; L A Parke; J Melancon-Kaplan; W P Weidanz
Journal:  Infect Immun       Date:  1989-12       Impact factor: 3.441

Review 2.  Into the eye of the cytokine storm.

Authors:  Jennifer R Tisoncik; Marcus J Korth; Cameron P Simmons; Jeremy Farrar; Thomas R Martin; Michael G Katze
Journal:  Microbiol Mol Biol Rev       Date:  2012-03       Impact factor: 11.056

3.  Inhibition of Rickettsia conorii growth by recombinant tumor necrosis factor alpha: enhancement of inhibition by gamma interferon.

Authors:  E Manor; I Sarov
Journal:  Infect Immun       Date:  1990-06       Impact factor: 3.441

4.  Effect of recombinant tumour necrosis factor on acute infection in mice with Toxoplasma gondii or Trypanosoma cruzi.

Authors:  C M Black; D M Israelski; Y Suzuki; J S Remington
Journal:  Immunology       Date:  1989-12       Impact factor: 7.397

5.  Malarial parasites and tumour cells are killed by the same component of tumour necrosis serum.

Authors:  J Taverne; N Matthews; P Depledge; J H Playfair
Journal:  Clin Exp Immunol       Date:  1984-08       Impact factor: 4.330

6.  Production of luminol-reactive oxygen radicals during Plasmodium vinckei infection.

Authors:  R Stocker; N H Hunt; I A Clark; M J Weidemann
Journal:  Infect Immun       Date:  1984-09       Impact factor: 3.441

7.  Recombinant tumour necrosis factor inhibits malaria parasites in vivo but not in vitro.

Authors:  J Taverne; J Tavernier; W Fiers; J H Playfair
Journal:  Clin Exp Immunol       Date:  1987-01       Impact factor: 4.330

8.  Longitudinal study on the in vitro immune response to Plasmodium falciparum in Sudan.

Authors:  J A Vande Waa; J B Jensen; M A Akood; R Bayoumi
Journal:  Infect Immun       Date:  1984-08       Impact factor: 3.441

Review 9.  Pathogenesis of malaria and clinically similar conditions.

Authors:  Ian A Clark; Lisa M Alleva; Alison C Mills; William B Cowden
Journal:  Clin Microbiol Rev       Date:  2004-07       Impact factor: 26.132

10.  Tumor necrosis factor production by human sarcoid alveolar macrophages.

Authors:  P R Bachwich; J P Lynch; J Larrick; M Spengler; S L Kunkel
Journal:  Am J Pathol       Date:  1986-12       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.